Patent · US Expired

Novel 6-amino-7-hydroxy-4,5,6,7-tetrahydro-imidazo[4,5,1-j-k][1]-benzazepin-2- (1H)-one

US4585770A · kind A · utility

9Cited by
3References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 12, 1983
Grant dateApr 29, 1986
Priority date
Expiry dateOct 12, 2003

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel 6-amino-7-hydroxy-4,5,6,7-tetrahydro-imidazo[4,5,l-j-k][1]-benzazepin-2-(1 H)-one derivatives of the formula ##STR1## wherein R is selected from the group consisting of hydrogen, alkyl of 1 to 8 carbon atoms optionally substituted with a hydroxyl, aryl and aryloxy of 6 to 10 carbon atoms, cycloalkyl of 3 to 7 carbon atoms optionally interrupted with a heteroatom optionally substituted with alkyl of 1 to 4 carbon atoms and the wavy lines indicates that the 7-OH and 6-amino have the trans configuration and their non-toxic, pharmaceutically acceptable acid addition salts having remarkable anti-hypertensive and hypotensive activity and vasodilatatory activity and their preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.